Yahoo! FinanceFinance Home - My Yahoo - Yahoo! - Help 

Tuesday, December 15, 2009, 3:57PM ET - U.S. Markets close in 3 mins.. Dow Down 0.48% Nasdaq Down 0.48%
Obagi Medical Products, Inc. (OMPI)At 3:41PM ET: 10.90  Down 0.39 (3.45%)  
MORE ON OMPI
Quotes
Charts
News & Info
Company
HereProfile
Analyst Coverage
Ownership
Financials

ProfileGet Profile for:
Obagi Medical Products, Inc.
3760 Kilroy Airport Way
Suite 500
Long Beach, CA 90806
United States - Map
Phone: 562-628-1007
Fax: 562-628-1008
Web Site: http://www.obagi.com

DETAILS 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:218

BUSINESS SUMMARY 
Obagi Medical Products, Inc., a specialty pharmaceutical company, develops and markets skincare products in the United States and internationally. The company develops and commercializes prescription-based, topical skin health systems, which enable physicians to treat a range of skin conditions. It offers Obagi Nu-Derm System, which includes prescription and OTC drugs that are used for the treatment of fine lines, wrinkles, acne, photo-damage, hyper pigmentation, melasma, laxity, and skin sallowness; Obagi Condition and Enhance Systems, which are used before and after surgical and non-surgical cosmetic procedures; Obagi-C Rx System, a combination of prescription, OTC drugs, and adjunctive cosmetic skin care products to treat skin conditions resulting from sun damage and the oxidative damage of free radicals; and Obagi Professional-C products, a line of proprietary, non-prescription products, which consist of vitamin C serums used to reduce the appearance of damage to the skin caused by ultraviolet radiation and other environmental influences. The company also offers ELASTIderm Eye and Decolletage, which increases the elasticity and skin tone of eyes, face, neckline, and chest; CLENZIderm M.D. Systems and SoluCLENZ Rx Gel for the treatment of acne; Obagi Rosaclear System, which is used for treating rosacea that reduces redness and flushing, as well as for the treatment of papules and pustules; Tretinoin, which is used for the treatment of acne in the United States; and Obagi Blue Peel System that is used for the treatment of fine lines, wrinkles, and hyper pigmentation. It markets its products through its domestic sales force and foreign distribution partners, as well as through the physician-dispensed skin channel to plastic surgeons, dermatologists, and other physicians that are focused on aesthetic and therapeutic skin care. The company was founded in 1988 and is headquartered in Long Beach, California.
Key Statistics

COMPANY WEBSITES 
  • Home Page
  • Search Yahoo! for:
    More on Obagi Medical Products, Inc.


    CORPORATE GOVERNANCE 
    Obagi Medical Products, Inc.'s Corporate Governance Quotient (CGQ®) as of 1-Dec-09 is better than 59.2% of Russell 3000 companies and 63.7% of Pharmaceuticals, Biotechnology & Life Sciences companies.
    Brought to you by Institutional Shareholder Services.

    KEY EXECUTIVES 
     PayExercised
    Mr. Steven R. Carlson , 52
    Chief Exec. Officer, Pres
    $ 483.00K $ 0
    Mr. Preston S. Romm , 55
    Chief Financial Officer, Principal Accounting Officer, Exec. VP of Fin., Exec. VP of Operations and Exec. VP of Admin.
    $ 209.00K $ 0
    Ms. Laura B. Hunter ,
    VP of International Sales & Marketing, Sec. and Gen. Counsel
    $ 96.00K $ 0
    Mr. David S. Goldstein , 48
    Exec. VP of Global Sales & Field Marketing
    $ 292.00K $ 0
    Ms. Judith C. Hattendorf , 66
    Sr. VP of Product Devel.
    N/A N/A
    Dollar amounts are as of 31-Dec-08 and compensation values are for the last fiscal year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of options exercised during the fiscal year.
    View Insiders


    Add to My Portfolio Add to Portfolio    Set Alert Set Alert    Email to a Friend Email to a Friend
    Get Profile for Another Symbol: Symbol Lookup
    Annual ReportsSector Analysis